LGND vs REGN: Which Stock is Better?
Side-by-side comparison of Ligand Pharmaceuticals Incorporated and Regeneron Pharmaceuticals Inc in 2026
LGND
Ligand Pharmaceuticals Incorporated
—
REGN
Regeneron Pharmaceuticals Inc
$635.45
Key Metrics Comparison
| Metric | LGND | REGN | Winner |
|---|---|---|---|
| Market Cap | $2.21B | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze LGND
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LGND or REGN a better investment?
Comparing LGND and REGN: Ligand Pharmaceuticals Incorporated has a market cap of $2.21B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LGND and REGN?
LGND (Ligand Pharmaceuticals Incorporated) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LGND or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LGND or REGN?
Both LGND and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: LGND or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: LGND or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $2.21B for LGND.
Should I buy LGND or REGN in 2026?
Both LGND and REGN have investment merit. LGND trades at $N/A while REGN trades at $635.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LGND and REGN stock?
Key differences: Market Cap ($2.21B vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy LGND or REGN in 2026?
The choice between LGND and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between LGND and REGN?
LGND (Ligand Pharmaceuticals Incorporated) has a market cap of $2.21B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.